Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression Open Access

• Abstract

Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis Open Access

• Abstract
• Supplementary data

Correlation without a cause: an epidemiological odyssey Free

• Abstract

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance Open Access

• Abstract
• Supplementary data

How Independent Are “Independent” Effects? Relative Risk Estimation When Correlated Exposures Are Measured Imprecisely Free

Enhancing national prevention and treatment services for sex workers in Zimbabwe: a process evaluation of the SAPPH-IRe trial Free

• Abstract

The Use of Backcalculation to Estimate the Prevalence of Severe Immunodeficiency Induced by the Human Immunodeficiency Virus in England and Wales Free

• Abstract

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV Open Access

• Abstract
• Supplementary data

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study Open Access

• Abstract
• Supplementary data

Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study Free

• Abstract
• Supplementary data

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys Free

• Abstract
• Supplementary data

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa Open Access

• Abstract
• Supplementary data

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK Open Access

• Abstract

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile Open Access

• Abstract
• Supplementary data

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection Free

• Abstract
• Supplementary data

Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa Open Access

• Abstract
• Supplementary data

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy Free

• Abstract
• Supplementary data

Factors Associated With Plasma IL-6 Levels During HIV Infection Get access

• Abstract

Factors Associated With Adherence Amongst 5295 People Receiving Antiretroviral Therapy as Part of an International Trial Get access

• Abstract

Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy Get access

• Abstract